Jay Pepose - 01 Nov 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Director
Signature
/s/ Stephanie Swan, by Power of Attorney
Issuer symbol
IRD
Transactions as of
01 Nov 2023
Net transactions value
$0
Form type
4
Filing time
13 Nov 2023, 17:46:46 UTC
Previous filing
08 Jun 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +35,000 +61% $0.000000 92,351 01 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest on the one-year anniversary of the date of grant.